Position in NEO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,128,810
+$2,932,207 QoQ
Shares Held
214,449
+1182.7% QoQ
Ownership
0.167%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#61
of 266 holders
Holding Since
Mar 2022
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NEO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ExodusPoint Capital Management, LP holds $101,462,417 across 18 Diagnostics & Research names. NEO ranks #9 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
164,518 | $24,682,635 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
32,661 | $16,374,918 | |
| 3 | QGEN |
Qiagen N.V.
|
321,161 | $12,557,395 | |
| 4 | A |
Agilent Technologies, Inc.
|
68,639 | $9,117,318 | |
| 5 | DHR |
Danaher Corp /De/
|
45,615 | $8,688,745 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
12,971 | $6,828,453 | |
| 7 | CDNA |
CareDx, Inc.
|
214,342 | $6,108,747 | |
| 8 | VCYT |
Veracyte, Inc.
|
94,044 | $5,523,204 |
All Filings in NEO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,128,810 | 214,449 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $196,603 | 16,718 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $2,343,768 | 320,625 | Shares | Sole | 2025-08-13 | |
| 2022-12-31 | $117,264 | 12,691 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $255,949 | 29,727 | Shares | Other | 2022-11-10 | |
| 2022-06-30 | $304,255 | 37,332 | Shares | Sole | 2022-08-22 | |
| 2022-03-31 | $227,217 | 18,701 | Shares | Other | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||